Singh et al. demonstrated that the coumarin derivative, SCD-1, could increase the survival of Aspergillus fumigatus-infected mice and decrease the colony counts in vital organs by treating with a dose of 200 mg/kg body weight orally or 100 mg/kg intraperitoneally, indicating that SCD-1 could be a potential strategy to treat aspergillosis (Singh et al., 2014). Here, SCD is linked to aspergillosis.